i2020 Accelerator of Torrey Pines Investment in Breakthrough Cancer Programs together with OrbiMed
07/30/20, 10:20 AM
Location
san diegoi2020, an accelerator program backed by the San Diego-based venture company Torrey Pines Investment, announces an up to $28.5M seed investment together with OrbiMed in four companies: Loch Lomond Therapeutics, Loch Eil Therapeutics, Loch Ness Therapeutics and Llyn Bala Therapeutics. Each of the four companies is engaged in innovative oncology discovery programs comprising breakthrough discovery-stage assets and drug targets.
Company Info
Location
san diego, california, united states
Additional Info
OrbiMed is a leading healthcare investment firm, with over $13 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, utilizing a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed maintains offices in New York City, San Francisco, Shanghai, Hong Kong, Mumbai and Herzliya. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies.